Tyrosine is a non-essential amino acid that serves as a building block for proteins and is a precursor for important substances such as dopamine, norepinephrine, epinephrine, thyroid hormones, and melanin.
Tyrosin is often considered in the context of tiredness, reduced capacity, brain fog, or chronic exhaustion. This short overview clarifies what the marker can contribute, where its limits are, and when symptom or illness context becomes more important.
Tyrosin matters when tiredness, cold intolerance, weight change, or broader thyroid-related complaints suggest endocrine involvement. The marker helps frame one important axis, but not every form of reduced capacity.
Tyrosin does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
Tyrosine is a conditionally essential amino acid — the body can typically produce it from another amino acid, phenylalanine, through enzymatic conversion. It plays a critical role in the synthesis of several vital molecules: the catecholamine neurotransmitters (dopamine, norepinephrine, and epinephrine), the thyroid hormones (thyroxine and triiodothyronine), and the skin pigment melanin.
Measurement of tyrosine in the blood (plasma or serum) is primarily used in the investigation of inherited metabolic disorders, most notably phenylketonuria (PKU) — in which phenylalanine cannot be converted to tyrosine, leading to low tyrosine levels — and various forms of tyrosinemia, where tyrosine accumulates to toxic levels due to enzyme deficiencies. The test may also be used to assess nutritional status in certain clinical contexts.
A tyrosine level below the reference range (commonly 30–120 µmol/L or 0.5–2.2 mg/dL, lab-dependent) may indicate impaired conversion from phenylalanine, as seen in phenylketonuria (PKU) where the enzyme phenylalanine hydroxylase is deficient. Low values can also be associated with protein malnutrition, malabsorption, or a diet very low in protein. In premature infants, transient hypertyrosinemia can paradoxically follow low tyrosine after initiating feeds, but initial low values often reflect overall protein insufficiency.
A tyrosine level above the reference range may be due to inherited disorders of tyrosine metabolism, collectively known as tyrosinemia. Type I tyrosinemia (fumarylacetoacetate hydrolase deficiency) leads to severe liver and kidney damage; type II (Richner-Hanhart syndrome) causes eye and skin lesions; type III is rare and neurological.
Transient high tyrosine levels are common in newborns (transient neonatal tyrosinemia), often due to immature enzyme systems. Acquired liver dysfunction, scurvy, or an extremely high-protein diet can also elevate tyrosine.
This result is not specific for ME/CFS or Long COVID. Read it together with the clinical question, symptoms, related findings and the laboratory reference range rather than in isolation.
Practical details are separated from the general FAQ so they are easier to find.
Fasting is often recommended because recent protein intake can temporarily raise amino acid levels. Typically, a 6- to 8-hour fast is advised, but specific instructions may vary. For newborn screening, samples are usually obtained regardless of feeding status, and age-appropriate reference ranges account for that.
Tyrosin matters when tiredness, cold intolerance, weight change, or broader thyroid-related complaints suggest endocrine involvement. The marker helps frame one important axis, but not every form of reduced capacity.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
You now know which questions can matter when reading this result. With Elara you can keep the value and its surrounding context together over time.
Save the lab value with its date so individual measurements do not get lost.
See previous measurements together instead of relying on a single snapshot.
View Tyrosine alongside symptom, energy, sleep and PEM entries without assuming one caused the other.
Export your history as a PDF — structured for the next check-up.
Normal tyrosine levels vary by age, fasting status, and laboratory method. In adults, a typical fasting plasma tyrosine range is 30–120 µmol/L (about 0.5–2.2 mg/dL). Newborns often have slightly higher levels, and reference intervals should be interpreted based on the specific lab’s age-adjusted normal values.
A low tyrosine level can suggest phenylketonuria (PKU) because the body cannot convert phenylalanine into tyrosine. It may also result from insufficient protein intake or malabsorption. In practice, tyrosine is often low in untreated PKU, while phenylalanine is markedly elevated.
Yes, abnormally high tyrosine can be toxic. It may signal a genetic disorder such as tyrosinemia type I, II, or III, or a transient condition in newborns. Acquired liver disease or very high protein diets can also raise tyrosine levels. Persistent elevation requires further investigation for an underlying metabolic defect.
Tyrosin does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
This biomarker gains value when it is connected to symptom patterns, daily function, and structured self-observation instead of being read in isolation.
Reduced capacity, multisystem symptoms, and delayed worsening often make more sense when the broader ME/CFS pattern is considered.
Markers linked to sleep, stress, recovery, hormones, or metabolism often become more useful when viewed through pacing and daily load management.
Questionnaires help connect biomarkers to symptom patterns, functional limits, and patient-reported change over time.
Markers from the same system can add useful context when a single lab value is hard to interpret on its own.
No individual medical review is documented.
This English content was created with AI assistance and automatically validated. This is not an individual medical review.
This information does not replace medical advice. Lab values should be assessed in the context of your medical history, the reason for testing and other findings. Elara provides health information for orientation — not diagnoses or treatment decisions.
Bring your lab values, symptoms and energy into one shared context — so you walk into your next appointment more informed and structured.
